Robert M Purick

Title: The Innovations of Robert M. Purick

Introduction

Robert M. Purick is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target HIV. With a total of 2 patents, his work has the potential to impact the treatment of AIDS and HIV infections.

Latest Patents

Purick's latest patents include innovative compounds such as Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides. These compounds serve as inhibitors of HIV protease and are effective against HIV replication. They are particularly useful in the prevention or treatment of HIV infections and AIDS. The patents describe methods for treating AIDS and preventing HIV infection, highlighting the effectiveness of these compounds against viral mutants resistant to existing protease inhibitors. Another significant invention is a sulfate salt of an HIV protease inhibitor, Compound A, which is beneficial in treating AIDS and HIV infections in both adults and children.

Career Highlights

Robert M. Purick is associated with Merck & Company, Inc., a leading pharmaceutical company. His work at Merck has allowed him to focus on developing innovative solutions for serious health issues, particularly in the realm of viral infections.

Collaborations

Throughout his career, Purick has collaborated with notable colleagues such as Richard John Varsolona and David Askin. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Robert M. Purick's contributions to the field of pharmaceuticals, particularly in the fight against HIV and AIDS, demonstrate his commitment to innovation and public health. His patents reflect a significant advancement in treatment options for those affected by these serious conditions.